CYP2C19 and End Stage Liver Disease: The results of bivariate correlation analysis show that sex, the genotype of CYP2C19, daily dose, prothrombin time activity (PTA), international normalized ratio (INR), platelet, and Model for end-stage liver disease (MELD) score are significant factors.